Niagen Bioscience, Inc.
NAGE· Nasdaq
NAGENiagen Bioscience, Inc.
Filed Mar 27, 2014 · 10-K · 89 days after period end · 0001415889-14-000961
| Metric | Q4 2013 | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Revenue | $2.40M | $3.52M | — | — |
| Net Income | -$724.32K | -$1.70M | — | — |
| EPS Diluted | -$0.01 | — | — |
Niagen Bioscience, Inc. · CIK 1386570 · Engraved from SEC EDGAR
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 28, 2013 · filed Mar 27, 2014 · 89 d after period end
